nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergonovine—ADRA1A—polycystic ovary syndrome	0.861	1	CbGaD
Ergonovine—Pergolide—ADRA1D—polycystic ovary syndrome	0.00136	0.125	CrCbGaD
Ergonovine—Lisuride—ADRA1D—polycystic ovary syndrome	0.00118	0.108	CrCbGaD
Ergonovine—Pergolide—ADRA1B—polycystic ovary syndrome	0.00116	0.106	CrCbGaD
Ergonovine—Ergotamine—ADRA1D—polycystic ovary syndrome	0.00114	0.104	CrCbGaD
Ergonovine—Bromocriptine—ADRA1D—polycystic ovary syndrome	0.0011	0.1	CrCbGaD
Ergonovine—Lisuride—ADRA1B—polycystic ovary syndrome	0.00101	0.0924	CrCbGaD
Ergonovine—Ergotamine—ADRA1B—polycystic ovary syndrome	0.00097	0.0888	CrCbGaD
Ergonovine—Bromocriptine—ADRA1B—polycystic ovary syndrome	0.000935	0.0856	CrCbGaD
Ergonovine—Pergolide—ADRA1A—polycystic ovary syndrome	0.000783	0.0717	CrCbGaD
Ergonovine—Ergotamine—ADRA1A—polycystic ovary syndrome	0.000653	0.0598	CrCbGaD
Ergonovine—Bromocriptine—ADRA1A—polycystic ovary syndrome	0.000629	0.0576	CrCbGaD
Ergonovine—HTR2C—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	6.54e-05	0.00051	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—LHB—polycystic ovary syndrome	6.51e-05	0.000507	CbGpPWpGaD
Ergonovine—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	6.51e-05	0.000507	CbGpPWpGaD
Ergonovine—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	6.49e-05	0.000506	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—GNAS—polycystic ovary syndrome	6.43e-05	0.000501	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	6.41e-05	0.000499	CbGpPWpGaD
Ergonovine—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	6.4e-05	0.000499	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—GNRH1—polycystic ovary syndrome	6.36e-05	0.000496	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—FSHR—polycystic ovary syndrome	6.36e-05	0.000496	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	6.36e-05	0.000495	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—YAP1—polycystic ovary syndrome	6.22e-05	0.000484	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	6.17e-05	0.00048	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—NPB—polycystic ovary syndrome	6.15e-05	0.000479	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—GAB1—polycystic ovary syndrome	6.13e-05	0.000478	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—SCT—polycystic ovary syndrome	6.1e-05	0.000475	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—LHB—polycystic ovary syndrome	6.1e-05	0.000475	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PTGER3—polycystic ovary syndrome	6.04e-05	0.00047	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—LHCGR—polycystic ovary syndrome	6.04e-05	0.00047	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	5.96e-05	0.000464	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—NMNAT3—polycystic ovary syndrome	5.91e-05	0.000461	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—ADRB2—polycystic ovary syndrome	5.89e-05	0.000459	CbGpPWpGaD
Ergonovine—ABCB1—Allograft Rejection—VEGFA—polycystic ovary syndrome	5.87e-05	0.000457	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—INSR—polycystic ovary syndrome	5.86e-05	0.000457	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	5.82e-05	0.000453	CbGpPWpGaD
Ergonovine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	5.81e-05	0.000453	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—SCT—polycystic ovary syndrome	5.71e-05	0.000445	CbGpPWpGaD
Ergonovine—HTR2C—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	5.68e-05	0.000443	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PTAFR—polycystic ovary syndrome	5.65e-05	0.00044	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—ADRB3—polycystic ovary syndrome	5.6e-05	0.000436	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—AKR1C3—polycystic ovary syndrome	5.57e-05	0.000434	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	5.56e-05	0.000433	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—LHB—polycystic ovary syndrome	5.54e-05	0.000431	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—ADRA1D—polycystic ovary syndrome	5.48e-05	0.000427	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—TNRC6B—polycystic ovary syndrome	5.48e-05	0.000427	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—GNAS—polycystic ovary syndrome	5.47e-05	0.000426	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	5.45e-05	0.000424	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—PGR—polycystic ovary syndrome	5.43e-05	0.000423	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—GNRH1—polycystic ovary syndrome	5.41e-05	0.000421	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—LPCAT2—polycystic ovary syndrome	5.41e-05	0.000421	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—SUOX—polycystic ovary syndrome	5.41e-05	0.000421	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—ADRA1B—polycystic ovary syndrome	5.33e-05	0.000416	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—INHBB—polycystic ovary syndrome	5.2e-05	0.000405	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—SCT—polycystic ovary syndrome	5.19e-05	0.000404	CbGpPWpGaD
Ergonovine—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	5.14e-05	0.0004	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PTGER3—polycystic ovary syndrome	5.14e-05	0.0004	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—LHCGR—polycystic ovary syndrome	5.14e-05	0.0004	CbGpPWpGaD
Ergonovine—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	5.07e-05	0.000395	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—GHRL—polycystic ovary syndrome	5.05e-05	0.000393	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—PLAT—polycystic ovary syndrome	5.05e-05	0.000393	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—ISYNA1—polycystic ovary syndrome	5.03e-05	0.000392	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	4.95e-05	0.000385	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—POMC—polycystic ovary syndrome	4.86e-05	0.000379	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PDE3B—polycystic ovary syndrome	4.85e-05	0.000378	CbGpPWpGaD
Ergonovine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	4.83e-05	0.000376	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—ATF1—polycystic ovary syndrome	4.81e-05	0.000375	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PTAFR—polycystic ovary syndrome	4.8e-05	0.000374	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—GHRL—polycystic ovary syndrome	4.73e-05	0.000369	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—TCF7L2—polycystic ovary syndrome	4.7e-05	0.000366	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—AKT2—polycystic ovary syndrome	4.67e-05	0.000364	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—ADRA1D—polycystic ovary syndrome	4.66e-05	0.000363	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—ADRA1B—polycystic ovary syndrome	4.54e-05	0.000353	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—NGFR—polycystic ovary syndrome	4.44e-05	0.000346	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	4.43e-05	0.000345	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—INHBB—polycystic ovary syndrome	4.42e-05	0.000344	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—FSHR—polycystic ovary syndrome	4.42e-05	0.000344	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—POMC—polycystic ovary syndrome	4.42e-05	0.000344	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—PRL—polycystic ovary syndrome	4.4e-05	0.000343	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—POMC—polycystic ovary syndrome	4.33e-05	0.000337	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—GHRL—polycystic ovary syndrome	4.3e-05	0.000335	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—AKR1C2—polycystic ovary syndrome	4.28e-05	0.000333	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—TEAD2—polycystic ovary syndrome	4.28e-05	0.000333	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—AKT2—polycystic ovary syndrome	4.24e-05	0.000331	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—ADRB2—polycystic ovary syndrome	4.18e-05	0.000325	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—RACGAP1—polycystic ovary syndrome	4.16e-05	0.000324	CbGpPWpGaD
Ergonovine—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	4.14e-05	0.000323	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PDE3B—polycystic ovary syndrome	4.13e-05	0.000321	CbGpPWpGaD
Ergonovine—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	4.09e-05	0.000318	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—ADRA1A—polycystic ovary syndrome	4.04e-05	0.000315	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—GHRL—polycystic ovary syndrome	4.02e-05	0.000313	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—FST—polycystic ovary syndrome	3.94e-05	0.000307	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	3.92e-05	0.000305	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—ADRB3—polycystic ovary syndrome	3.89e-05	0.000303	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—GNAS—polycystic ovary syndrome	3.87e-05	0.000302	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	3.87e-05	0.000301	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—LHB—polycystic ovary syndrome	3.85e-05	0.0003	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	3.81e-05	0.000297	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—GNRH1—polycystic ovary syndrome	3.76e-05	0.000293	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—FSHR—polycystic ovary syndrome	3.76e-05	0.000293	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—NCOR1—polycystic ovary syndrome	3.69e-05	0.000287	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—POMC—polycystic ovary syndrome	3.68e-05	0.000287	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—GHRL—polycystic ovary syndrome	3.65e-05	0.000285	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	3.64e-05	0.000284	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—AKR1C1—polycystic ovary syndrome	3.64e-05	0.000284	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—GNAS—polycystic ovary syndrome	3.63e-05	0.000283	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—NRG1—polycystic ovary syndrome	3.62e-05	0.000282	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—SCT—polycystic ovary syndrome	3.6e-05	0.000281	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	3.58e-05	0.000279	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—ADRB2—polycystic ovary syndrome	3.56e-05	0.000277	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	3.54e-05	0.000276	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	3.53e-05	0.000275	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—MTNR1B—polycystic ovary syndrome	3.44e-05	0.000268	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	3.4e-05	0.000265	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—FGF18—polycystic ovary syndrome	3.38e-05	0.000263	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—RBP4—polycystic ovary syndrome	3.35e-05	0.000261	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—FST—polycystic ovary syndrome	3.35e-05	0.000261	CbGpPWpGaD
Ergonovine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	3.34e-05	0.00026	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	3.33e-05	0.00026	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	3.33e-05	0.00026	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	3.33e-05	0.000259	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—ADRB3—polycystic ovary syndrome	3.31e-05	0.000258	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—GNAS—polycystic ovary syndrome	3.3e-05	0.000257	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—LHB—polycystic ovary syndrome	3.27e-05	0.000255	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—STAR—polycystic ovary syndrome	3.24e-05	0.000252	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	3.24e-05	0.000252	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—GNRH1—polycystic ovary syndrome	3.2e-05	0.000249	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—YAP1—polycystic ovary syndrome	3.13e-05	0.000244	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—IRS2—polycystic ovary syndrome	3.1e-05	0.000242	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	3.1e-05	0.000241	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	3.1e-05	0.000241	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	3.09e-05	0.000241	CbGpPWpGaD
Ergonovine—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	3.09e-05	0.000241	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—GAB1—polycystic ovary syndrome	3.08e-05	0.00024	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—SCT—polycystic ovary syndrome	3.06e-05	0.000239	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—LEP—polycystic ovary syndrome	3.04e-05	0.000237	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	3.02e-05	0.000236	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—INSR—polycystic ovary syndrome	2.95e-05	0.00023	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	2.92e-05	0.000228	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	2.9e-05	0.000226	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	2.89e-05	0.000225	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—FGF18—polycystic ovary syndrome	2.87e-05	0.000224	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—RBP4—polycystic ovary syndrome	2.85e-05	0.000222	CbGpPWpGaD
Ergonovine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	2.84e-05	0.000221	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—GNAS—polycystic ovary syndrome	2.8e-05	0.000218	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.8e-05	0.000218	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.76e-05	0.000215	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	2.76e-05	0.000215	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PGR—polycystic ovary syndrome	2.73e-05	0.000213	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	2.72e-05	0.000212	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—IRS1—polycystic ovary syndrome	2.71e-05	0.000211	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—YAP1—polycystic ovary syndrome	2.66e-05	0.000207	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	2.63e-05	0.000205	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	2.63e-05	0.000205	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—GAB1—polycystic ovary syndrome	2.62e-05	0.000204	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—POMC—polycystic ovary syndrome	2.61e-05	0.000203	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—INS—polycystic ovary syndrome	2.59e-05	0.000202	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PLAT—polycystic ovary syndrome	2.54e-05	0.000198	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—GHRL—polycystic ovary syndrome	2.54e-05	0.000198	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—LHB—polycystic ovary syndrome	2.51e-05	0.000196	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—IGF1—polycystic ovary syndrome	2.51e-05	0.000195	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—INSR—polycystic ovary syndrome	2.51e-05	0.000195	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—AKT2—polycystic ovary syndrome	2.51e-05	0.000195	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	2.46e-05	0.000191	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—POMC—polycystic ovary syndrome	2.45e-05	0.000191	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—ATF1—polycystic ovary syndrome	2.42e-05	0.000189	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.38e-05	0.000186	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.38e-05	0.000186	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	2.38e-05	0.000185	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.36e-05	0.000184	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—AKT2—polycystic ovary syndrome	2.35e-05	0.000183	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.35e-05	0.000183	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PGR—polycystic ovary syndrome	2.32e-05	0.000181	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—NGFR—polycystic ovary syndrome	2.24e-05	0.000174	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—POMC—polycystic ovary syndrome	2.22e-05	0.000173	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PRL—polycystic ovary syndrome	2.22e-05	0.000173	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	2.21e-05	0.000172	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	2.19e-05	0.00017	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—GHRL—polycystic ovary syndrome	2.16e-05	0.000168	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PLAT—polycystic ovary syndrome	2.16e-05	0.000168	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.13e-05	0.000166	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	2.12e-05	0.000165	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.1e-05	0.000164	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	2.09e-05	0.000163	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—POMC—polycystic ovary syndrome	2.08e-05	0.000162	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—ATF1—polycystic ovary syndrome	2.06e-05	0.00016	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	2.04e-05	0.000159	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.01e-05	0.000156	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	2e-05	0.000156	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	2e-05	0.000156	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	1.96e-05	0.000153	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—GNAS—polycystic ovary syndrome	1.95e-05	0.000152	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	1.94e-05	0.000151	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—IL6—polycystic ovary syndrome	1.92e-05	0.000149	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—NGFR—polycystic ovary syndrome	1.9e-05	0.000148	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—POMC—polycystic ovary syndrome	1.89e-05	0.000147	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PRL—polycystic ovary syndrome	1.88e-05	0.000147	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.86e-05	0.000145	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	1.83e-05	0.000143	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—NRG1—polycystic ovary syndrome	1.82e-05	0.000142	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.82e-05	0.000141	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	1.8e-05	0.00014	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.79e-05	0.000139	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	1.78e-05	0.000139	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	1.7e-05	0.000132	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—GNAS—polycystic ovary syndrome	1.66e-05	0.000129	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.64e-05	0.000128	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.58e-05	0.000123	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—IRS2—polycystic ovary syndrome	1.56e-05	0.000122	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—TH—polycystic ovary syndrome	1.56e-05	0.000121	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—NRG1—polycystic ovary syndrome	1.55e-05	0.000121	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	1.55e-05	0.000121	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—LEP—polycystic ovary syndrome	1.53e-05	0.000119	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	1.52e-05	0.000118	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	1.51e-05	0.000118	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	1.47e-05	0.000114	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	1.43e-05	0.000111	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—IRS1—polycystic ovary syndrome	1.36e-05	0.000106	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	1.35e-05	0.000105	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—IRS2—polycystic ovary syndrome	1.33e-05	0.000103	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—POMC—polycystic ovary syndrome	1.31e-05	0.000102	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	1.31e-05	0.000102	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—INS—polycystic ovary syndrome	1.3e-05	0.000102	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—LEP—polycystic ovary syndrome	1.3e-05	0.000101	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	1.27e-05	9.92e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—IGF1—polycystic ovary syndrome	1.26e-05	9.83e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—AKT2—polycystic ovary syndrome	1.26e-05	9.82e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	1.26e-05	9.81e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	1.21e-05	9.45e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	1.21e-05	9.42e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.2e-05	9.34e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	1.19e-05	9.3e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—IRS1—polycystic ovary syndrome	1.16e-05	9.02e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	1.15e-05	8.96e-05	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—IL6—polycystic ovary syndrome	1.13e-05	8.83e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	1.13e-05	8.79e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—POMC—polycystic ovary syndrome	1.12e-05	8.69e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	1.11e-05	8.65e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—INS—polycystic ovary syndrome	1.11e-05	8.64e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—IGF1—polycystic ovary syndrome	1.07e-05	8.36e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—AKT2—polycystic ovary syndrome	1.07e-05	8.35e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	1.07e-05	8.35e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.02e-05	7.94e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—IL6—polycystic ovary syndrome	9.65e-06	7.52e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—TH—polycystic ovary syndrome	9.61e-06	7.48e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	9.35e-06	7.28e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	8.79e-06	6.85e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	8.69e-06	6.77e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—POMC—polycystic ovary syndrome	8.57e-06	6.68e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—INS—polycystic ovary syndrome	8.52e-06	6.64e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.24e-06	6.42e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—IL6—polycystic ovary syndrome	8.21e-06	6.39e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	7.84e-06	6.11e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	7.47e-06	5.82e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	7.08e-06	5.52e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	7.01e-06	5.46e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	6.6e-06	5.14e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—IL6—polycystic ovary syndrome	5.7e-06	4.44e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	5.35e-06	4.17e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	5.28e-06	4.11e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—INS—polycystic ovary syndrome	5.25e-06	4.09e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—IL6—polycystic ovary syndrome	4.85e-06	3.78e-05	CbGpPWpGaD
